Does indoleamine 2,3-dioxygenase serve as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells?
The indoleamine 2,3-dioxygenase screened with the GeneChip was positively associated with paclitaxel resistance and with impaired survival in patients with serous-type ovarian cancer.
Changes in functional capacity after short and long term detraining are affected by age in elderly adults.